Kuemmel S, Tondini CA, Abraham J, Nowecki Z, et al. Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study. Breast Cancer Res Treat 2021 Mar 21. pii: 10.1007/s10549-021-06145.
PMID: 33748921